Hertie-Institut für klinische Hirnforschung

The Hertie Institute for Clinical Brain Research (HIH) was established in 2002 by the University of Tübingen and the non-profit Hertie Foundation in Frankfurt. The Institute combines neuroscientific research with the clinical treatment of brain disorders. The Institute is located in a research building on the Schnarrenberg campus in Tübingen. The HIH has four divisions: General Neurology (Interim Director: Prof. Arthur Melms) Cognitive Neurology (Director: Prof. Hans-Peter Thier) Neurodegenerative Diseases (Director: Prof. Thomas Gasser) Cell biology of neurological diseases (Director: Prof. Mathias Jucker) The HIH employs around 200 scientists under the leadership of 10 renowned professors, who investigate the information-theoretical and neuronal basics of important brain functions such as perception, memory and learning. These findings are used to prevent and treat brain diseases such as Alzheimer’s, Parkinson’s, stroke, tumours or multiple sclerosis. In addition, the scientists analyse brain-oriented applications for technological applications, for example traffic safety systems. The Hertie Institute for Clinical Brain Research has close structural connections with the Hospital for Neurology, both of which are part of the Centre of Neurology, a multifunctional institution which is able to offer clinical brain research, medical treatment and scientific education.